DK708188A - 5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids - Google Patents

5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids

Info

Publication number
DK708188A
DK708188A DK708188A DK708188A DK708188A DK 708188 A DK708188 A DK 708188A DK 708188 A DK708188 A DK 708188A DK 708188 A DK708188 A DK 708188A DK 708188 A DK708188 A DK 708188A
Authority
DK
Denmark
Prior art keywords
dideoxy
imino
methyl
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
DK708188A
Other languages
English (en)
Other versions
DK175113B1 (da
DK708188D0 (da
Inventor
Raymond Allen Dwek
Georg William John Fleet
Thomas William Rademacher
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK708188D0 publication Critical patent/DK708188D0/da
Publication of DK708188A publication Critical patent/DK708188A/da
Application granted granted Critical
Publication of DK175113B1 publication Critical patent/DK175113B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198807081A 1987-12-21 1988-12-20 Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV DK175113B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13621987A 1987-12-21 1987-12-21
US13621987 1987-12-21
US07/249,144 US4999360A (en) 1987-12-21 1988-09-26 Method of inhibiting virus
US24914488 1988-09-26

Publications (3)

Publication Number Publication Date
DK708188D0 DK708188D0 (da) 1988-12-20
DK708188A true DK708188A (da) 1989-06-22
DK175113B1 DK175113B1 (da) 2004-06-07

Family

ID=26834131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198807081A DK175113B1 (da) 1987-12-21 1988-12-20 Anvendelse af 5- og 6-leddede heterocycliske forbindelser til fremstilling af et præparat til behandling af patienter inficeret med HIV

Country Status (16)

Country Link
US (1) US4999360A (da)
EP (1) EP0322395B1 (da)
JP (1) JP2538014B2 (da)
KR (1) KR910009994B1 (da)
AT (1) ATE87206T1 (da)
AU (1) AU607834B2 (da)
CA (1) CA1316929C (da)
DE (1) DE3879653T2 (da)
DK (1) DK175113B1 (da)
FI (1) FI93210C (da)
IE (1) IE63095B1 (da)
IL (1) IL88742A (da)
NO (1) NO172340C (da)
NZ (1) NZ227410A (da)
OA (1) OA08937A (da)
PT (1) PT89267B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2086323T3 (es) * 1988-11-03 1996-07-01 Searle & Co Derivados del didesoxi-arabinitol como compuestos antiviricos.
US4894388A (en) * 1988-12-22 1990-01-16 Monsanto Company Glycosidase inhibitors and use thereof
US5100797A (en) * 1989-06-27 1992-03-31 Monsanto Company Fucosidase inhibitors
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
IT1239950B (it) * 1990-03-28 1993-11-27 Zambon Spa Processo per la preparazione di composti con attivita' analgesica centrale
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5290948A (en) * 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
GB9026271D0 (en) * 1990-12-03 1991-01-16 Alphey Thomas J W Control of parasitic nematodes(a)
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
HUP9901132A2 (hu) * 1995-09-08 1999-07-28 Novo Nordisk A/S 2-Alkilpirrolidinek
CN102399228B (zh) * 2010-09-08 2013-10-16 中国科学院成都生物研究所 N-烷基多羟基哌啶衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3507019A1 (de) * 1985-02-28 1986-08-28 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.

Also Published As

Publication number Publication date
IL88742A (en) 1993-08-18
DK175113B1 (da) 2004-06-07
US4999360A (en) 1991-03-12
AU2706888A (en) 1989-06-22
IL88742A0 (en) 1989-07-31
IE883794L (en) 1989-06-21
FI885880A0 (fi) 1988-12-20
JPH01230517A (ja) 1989-09-14
JP2538014B2 (ja) 1996-09-25
KR910009994B1 (ko) 1991-12-10
DK708188D0 (da) 1988-12-20
EP0322395A1 (en) 1989-06-28
NO172340B (no) 1993-03-29
OA08937A (fr) 1989-10-31
IE63095B1 (en) 1995-03-22
FI93210C (fi) 1995-03-10
PT89267A (pt) 1989-12-29
NO885655L (no) 1989-06-22
FI885880A (fi) 1989-06-22
NZ227410A (en) 1991-06-25
NO885655D0 (no) 1988-12-20
EP0322395B1 (en) 1993-03-24
CA1316929C (en) 1993-04-27
KR890009389A (ko) 1989-08-01
AU607834B2 (en) 1991-03-14
ATE87206T1 (de) 1993-04-15
DE3879653T2 (de) 1993-10-14
PT89267B (pt) 1993-12-31
FI93210B (fi) 1994-11-30
DE3879653D1 (de) 1993-04-29
NO172340C (no) 1993-07-07

Similar Documents

Publication Publication Date Title
DE69131317T2 (de) HIV-Proteaseinhibitoren
DK708188D0 (da) 5- og 6-leddede heterocycliske forbindelser og farmaceutisk acceptable saltderivater heraf til anvendelse ved behandling af aids
ES2058342T3 (es) Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii.
NO931867L (no) Aminokinolonderivater substituert med arylgrupper og aromatiske heteocykliske grupper, samt middel mot HIV
DK73193D0 (da) Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner
CA2075173A1 (en) Compounds and methods for inhibition of hiv and related viruses
ATE142496T1 (de) Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
ATE123024T1 (de) 4-aminopyridinderivate.
EP0594795A4 (en) MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT.
IE883793L (en) Method of inhibiting human immunodeficiency virus
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0523013T3 (da) Anvendelse af benzimidazolin-2-oxo-1-carboxylsyrederivater ved behandling af organiske mentale sygdomme
DE69015411T2 (de) 5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one und -thione und deren Verwendung bei der Vorbeugung und und Behandlung von AIDS.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK